Press Releases
Search
-
02 Mar 2022
Financial Information
bioMérieux – 2021 Financial Results
The Board of Directors of bioMérieux, a world leader in the field of in vitro diagnostics, met on March 1 under the chairmanship of Alexandre Mérieux and approved the audited consolidated financial st...
-
17 Feb 2022
Business & Solutions
MYACUTECASE™, a free mobile application by bioMérieux to support clinicians in decision-making and monitoring of patients using emergency and critical care diagnostics
bioMérieux, a world leader in the field of in vitro diagnostics, launches MYACUTECASETM. This mobile application, the first of a kind developed by bioMérieux, is an aid in the interpretation of VIDAS®...
-
06 Jan 2022
Partnerships
French multidisciplinary consortium ARPEGE awarded public funding of close to €9 million to fight antibiotic resistance
The ARPEGE project aims to develop a set of solutions to strengthen the ability of healthcare institutions to fight antibiotic resistance. The consortium, led by Antabio, has been awarded close to €9 ...
-
14 Dec 2021
Corporate Social Responsibility
Corporate Social Responsibility: bioMérieux recently received a series of official recognitions from independent third parties
bioMérieux, a world leader in the field of in vitro diagnostics, recently received a series of official recognitions for its achievements in Corporate Social Responsibility (CSR) from independent thir...
-
10 Dec 2021
Financial Information
bioMérieux – Increased outlook for full-year 2021
bioMérieux, a world leader in the field of in vitro diagnostics, today released its adjusted outlook for full-year 2021. In light of stronger than expected respiratory panels sales in Q4, full-year 20...
-
01 Dec 2021
Business & Solutions
bioMérieux molecular tests efficiently detect SARS-CoV-2 Omicron variant
As the incidence of infections with the SARS-CoV-2 Omicron variant (B.1.1. 529) continues to rise, there is much concern about diagnostic tests ability to efficiently detect this multi-mutated form of...